Ingalls & Snyder LLC Regeneron Pharmaceuticals, Inc. Transaction History

Ingalls & Snyder LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 24, 2019	SELL	$335.82 - $403.04 $169,589 - $203,535	-505 Closed	0 $0
Q3 2018 Oct 24, 2018	BUY	$351.14 - $408.51 $177,325 - $206,297	505 New	505 $204,000
Q1 2018 Apr 17, 2018	SELL	$315.82 - $393.78 $1.95 Million - $2.43 Million	-6,165 Closed	0 $0
Q4 2017 Jan 19, 2018	SELL	$358.63 - $469.95 $58,456 - $76,601	-163 Reduced 2.58%	6,165 $2.32 Million
Q3 2017 Oct 20, 2017	BUY	$431.38 - $504.0 $2.73 Million - $3.19 Million	6,328	6,328 $2.83 Million

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.